Company Declares Quarterly Dividend
The Company announced today the declaration of its regular quarterly cash dividend of 5 cents per share, payable on September 15, 2020, to shareholders of record as of September 1, 2020. The number of common shares outstanding as of July 29, 2020 was 223.8 million.
Share Repurchases
The Company intends to resume share repurchases in 2020 to effectively manage dilution, subject to market conditions and prevailing economic factors. In addition, the Company’s Board of Directors has approved an extension of its existing $100 million share repurchase authorization by one year, which now expires in February 2022. As of the date of this release, approximately $85.5 million remains available under the Company’s existing share repurchase authorization.
Company Repays $120 Million Outstanding On Its Securitized Revolving Financing Facility
In July 2020, the Company repaid the $120 million outstanding balance on its revolving financing facility of Variable Funding Senior Secured Notes that it had drawn down in March 2020 in response to the COVID-19 pandemic. In addition, as previously announced in June, the Company has added an additional $100 million of revolving financing capacity through a new Securitized Variable Funding Senior Secured Notes facility. As a result of these actions, the Company now has $250 million of capacity within its Securitized revolving financing facilities, none of which is currently drawn down as borrowings.
Outlook
As previously announced, due to the current unprecedented global market and economic conditions, the Company withdrew its outlook for the 2020 fiscal year that was issued on February 26, 2020 and its 2021-2024 long-term outlook that was provided at its Investor day in October 2019. The Company intends to provide an updated financial outlook when it can reasonably estimate the impact of the COVID-19 pandemic and changing market conditions.
Conference Call and Webcast Scheduled for 8:30 a.m. Today, August 5
The Company will host a conference call on Wednesday, August 5 at 8:30 a.m. ET, with a simultaneous webcast from the Company’s Investor Relations website at www.irwendys.com. The related presentation materials will also be available on the Company’s Investor Relations website. The live conference call will be available by telephone at (866) 211-4759 for domestic callers and (647) 689-6752 for international callers. An archived webcast and presentation materials will be available on the Company’s Investor Relations website.
Forward-Looking Statements
This release contains certain statements that are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”), including statements regarding the impacts that the novel coronavirus (COVID-19) pandemic may have on our future operations and financial condition. Generally, forward-looking statements include the words “may,” “believes,” “plans,” “expects,” “anticipates,” “intends,” “estimate,” “goal,” “upcoming,” “outlook,” “guidance” or the negation thereof, or similar expressions. In addition, all statements that address future operating, financial or business performance, strategies or initiatives, future efficiencies or savings, anticipated costs or charges, future capitalization, anticipated impacts of recent or pending investments or transactions and statements expressing general views about future results or brand health are forward-looking statements within the meaning of the Reform Act. Forward-looking statements are based on the Company’s expectations at the time such statements are made, speak only as of the dates they are made and are susceptible to a number of risks, uncertainties and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company’s actual results, performance and achievements may differ materially from any future results, performance or achievements expressed or implied by the Company’s forward-looking statements.
4